Loading organizations...

§ Private Profile · Boston, MA, USA
AI-powered clinical intelligence software for health plans and providers, automating prior authorization and utilization management.
Cohere Health is a United States-based enterprise that develops artificial intelligence-powered clinical software to streamline complex prior authorization processes for healthcare payers and medical providers. The commercial software platform automates utilization management workflows to significantly reduce administrative burdens, enabling approximately 85 percent of prior authorization requests to be approved in real time. Operating as a Series C stage organization, the company is guided by a corporate leadership team that includes Board Chair Dr. Gary Gottlieb and has earned executive accolades such as the EY Entrepreneur Of The Year award. The core technology has secured notable industry recognition from major healthcare analyst firms, including consecutive placements in the 2024 and 2025 Gartner Hype Cycle reports alongside three distinct KLAS Points of Light awards. The healthcare technology business Cohere Health was officially founded in 2019 by Siva Namasivayam.
Cohere Health has raised $236.0M across 5 funding rounds.
Cohere Health has raised $236.0M in total across 5 funding rounds.
Cohere Health is a clinical intelligence company building an AI-powered platform that transforms utilization management (UM) in healthcare by streamlining prior authorization processes between health plans (payers) and providers.[1][2] It serves health plans and over 660,000 providers, processing more than 12 million requests annually, solving the problem of administrative burdens, delays in care access, high denial rates, and elevated costs through automation that auto-approves up to 90% of requests while aligning decisions with evidence-based care paths.[3][5] Key metrics include 47% admin-cost savings, 70% faster care access, 93-94% provider satisfaction, and an 8x ROI on payments, with recognition as a Gartner Hype Cycle leader, Top 5 LinkedIn Startup (2023-2024), and three-time KLAS Points of Light winner.[2][3]
The platform integrates clinically trained AI, including tools like Review Assist and ambient prior authorization via partnerships (e.g., Microsoft Dragon Copilot), to handle structured/unstructured data for real-time decisions, reducing clinical review time by up to 50% and enabling scalable UM as a service or via APIs.[3][5][6]
Cohere Health was founded on the premise that every patient deserves clear care guidance, physicians need decision support, and health plans must deliver better member outcomes—turning prior authorization from an obstacle into an ally.[4] The company emerged from a commitment to unite payers and providers through science, technology, and expertise, rethinking silos in healthcare to create win-win-win scenarios.[1][4] Core values like "purpose drives performance" and "rethink the status quo" guide its mission, with early traction built on evidence-based care paths integrated into UM workflows.[2][4]
Investors including Flare Capital Partners, Define Ventures, Deerfield, Polaris Partners, and Longitude Capital fueled growth, leading to accolades like the TripleTree iAward, Fierce 15, and CB Insights Digital Health 150.[1] Pivotal moments include launching Cohere Unify for AI-driven insights and recent AI tools like Review Assist (enhancing complex reviews) and point-of-care integrations, processing millions of requests with high automation rates.[3][5]
Cohere Health rides the AI in healthcare trend, specifically targeting prior authorization inefficiencies amid rising UM scrutiny from regulations like CMS rules mandating faster decisions and reduced burdens.[1][3] Timing aligns with payer-provider friction costing billions annually, amplified by post-pandemic backlogs and value-based care shifts favoring evidence-driven automation over transactional reviews.[2][7] Market forces like exploding clinical data volumes and LLM advancements enable its edge in real-time, responsible AI—processing unstructured docs that legacy systems ignore—while partnerships (e.g., Microsoft) extend reach into EHRs.[5][6]
It influences the ecosystem by setting benchmarks for collaborative UM, boosting provider satisfaction to 94%, and enabling scalable predictions that support millions in care access, potentially reshaping healthcare economics toward efficiency and outcomes.[3][5]
Cohere Health's momentum—handling 12M+ requests, 90% automation, and AI expansions like Review Assist—positions it to dominate AI-driven UM as health plans prioritize cost optimization amid 2025 regulatory pressures.[3][5] Next steps likely include deeper EHR integrations, expanded ML via SID for more segments, and global scaling, leveraging Gartner validation and investor backing.[1][6] Trends like ambient AI and multimodal LLMs will amplify its platform, evolving influence from UM specialist to full-care-journey intelligence leader. This builds on its core premise: uniting stakeholders for better care, delivering sustained growth in a $4T+ U.S. healthcare market.
Cohere Health has raised $236.0M in total across 5 funding rounds.
Cohere Health's investors include Temasek, Define Ventures, Flare Capital Partners, Anthony Philippakis, Polaris Partners, Deerfield Management, Lynne Chou O'Keefe, Michael Greeley, Longitude Capital, David Barrett.
Cohere Health has raised $236.0M across 5 funding rounds. Most recently, it raised $90.0M Series C in May 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2025 | $90M Series C | Temasek | Define Ventures, Flare Capital Partners, Anthony Philippakis, Polaris Partners | Announced |
| Feb 2, 2024 | $50M Venture Round | Deerfield Management | Lynne Chou O’keefe, Michael Greeley, Longitude Capital, Polaris Partners | Announced |
| Jan 1, 2024 | $50M Series C | — | Define Ventures, Flare Capital Partners, Anthony Philippakis, Polaris Partners | Announced |
| Apr 1, 2021 | $36M Series B | David Barrett | Define Ventures, Flare Capital Partners, Anthony Philippakis, Polaris Partners, Deerfield Management, Longitude Capital | Announced |
| Jul 1, 2020 | $10M Series A | Flare Capital Partners | Define Ventures, Anthony Philippakis, Polaris Partners | Announced |